Chester County News and Community Website
MALVERN, PA — Endo is presenting new clinical data on collagenase clostridium histolyticum (CCH) as a potential nonsurgical treatment for plantar fibromatosis (PFI) and plantar fasciitis (PFA) during the American …
Endo Highlights New Data on Potential Treatments for Painful Foot Disorders at Orthopaedic Conference Read More
PLYMOUTH MEETING, PA — A new study published in the September 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the effectiveness of a specialized tool for identifying …
Study Validates GO-PIMs Tool for Safer Cancer Care in Older Adults Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in the DUBSTENT DIABETES trial, a new clinical study designed to evaluate whether combining two …
Teleflex Launches Clinical Trial Testing Dual-Device Heart Procedure for Diabetic Patients Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections tied to ready-to-eat meals produced by …
CDC Issues Food Safety Alert Over Multistate Salmonella Outbreak Linked to Metabolic Meals Read More
WEST CHESTER, PA — The Chester County Health Department has released its schedule of community vaccination clinics for fall 2025, offering flu and COVID-19 shots at multiple locations across the …
Chester County Health Department Announces 2025 Seasonal Vaccine Clinics Read More
WASHINGTON, D.C. – The U.S. Department of Health and Human Services announced the revival of the Task Force on Safer Childhood Vaccines, a federal panel first created by Congress to …
HHS Reinstates Federal Task Force on Childhood Vaccine Safety Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Papzimeos (zopapogene imadenovec-drba), marking the first approved medical therapy for adults with recurrent respiratory papillomatosis (RRP), a rare …
FDA Approves First Immunotherapy for Rare Respiratory Papillomatosis Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received a key regulatory boost in its bid to bring a gene therapy for Stargardt disease to market, with the European Medicines …
Ocugen Gains EMA Backing for Single Pivotal Trial to Support Stargardt Disease Gene Therapy Approval Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has announced a sweeping plan to wind down its mRNA vaccine development initiatives under the Biomedical Advanced Research …
HHS to Phase Out mRNA Vaccine Projects, Redirect Funding to Broader Platforms Read More
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has filed a complaint to stop Edwards Lifesciences Corp. from acquiring JenaValve Technology, Inc., citing fears the deal would significantly reduce competition …
FTC Moves to Block Edwards Lifesciences’ $945 Million Acquisition of JenaValve Over Competition Concerns Read More